Offer - Urjas Oil for just ₹ 1 X
Jardiance Met 5mg/500mg Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Jardiance Met 5mg/500mg Tablet safe for pregnant women?
Jardiance Met should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Jardiance Met 5mg/500mg Tablet safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Jardiance Met. Immediately discontinue Jardiance Met if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Jardiance Met 5mg/500mg Tablet on the Kidneys?
Jardiance Met has very mild side effects on the kidneys.
What is the effect of Jardiance Met 5mg/500mg Tablet on the Liver?
Using Jardiance Met does not have any harmful effects on the liver.
What is the effect of Jardiance Met 5mg/500mg Tablet on the Heart?
Jardiance Met is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Jardiance Met 5mg/500mg Tablet unless your doctor advises you to do so -
Is this Jardiance Met 5mg/500mg Tablet habit forming or addictive?
Jardiance Met 5mg/500mg Tablet does not cause addiction.
Interaction between Food and Jardiance Met 5mg/500mg Tablet
You can take Jardiance Met 5mg/500mg Tablet with food.
Interaction between Alcohol and Jardiance Met 5mg/500mg Tablet
Taking Jardiance Met 5mg/500mg Tablet with alcohol can have severely harmful effects on your health.
Yes, you can take Jardiance Met with gliclazide, no harmful interactions have been reported between them. However, it is not necessary that no interaction can happen between these two. But before taking such kind of combination you must consult your doctor.
Lactic acidosis associated with Jardiance Met treatment is a rare but fatal adverse effect. Lactic acidosis appears to result from biguanide interference causing an increase in production and decrease in clearance of lactate leading to higher cellular lactate levels. A decrease in pyruvate carboxylase activity, the rate-limiting enzyme in the formation of glucose from lactate, can also decrease hepatic metabolism of lactate. leading to increasing lactic acidosis. Signs and symptoms of Jardiance Met induced lactic acidosis are nonspecific and include anorexia, nausea, vomiting, altered level of consciousness, hyperpnoea, abdominal pain, and thirst.
Jardiance Met increases the sensitivity of insulin, young women with PCOS often have elevated insulin levels and are more likely to develop diabetes. It is often prescribed for women with PCOS to help prevent diabetes. A lifestyle that includes healthy nutrition and daily exercise is the most important part of a PCOS treatment plan.
Jardiance Met works by decreasing the hepatic glucose production. It also works to lower blood sugar by increasing your sensitivity to insulin and decreasing the amount of glucose that is absorbed from the food you eat.
Yes, Jardiance Met is safe to use, many people have side effects at first, they usually diminish and then go away completely in a few weeks. A few people find they cannot tolerate metformin, there are other drugs but metformin is usually the first choice. It is very safe
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Jardiance® (empagliflozin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 491-493